Is Palantir Stock a Buy on the Dip as Revenue Continues to Surge?

Palantir reported Q3 revenue of $2.31 billion, up 96% year over year and above its $2.16–$2.164 billion forecast and $2.18 billion analyst consensus; adjusted EPS was $0.44 versus $0.41 expected. U.S. commercial revenue grew 148% to $984 million, while net revenue retention rose to 165% from 157% in Q2. The company raised full-year revenue guidance to $8.53–$8.534 billion, implying 82% growth, and forecast Q4 revenue of $2.649–$2.653 billion; the article notes the shares dipped on the news and were down more than 15% over the prior year.

Analysis

The key debate is not whether demand exists, but whether customer expansion converts into durable, diversified revenue quickly enough to support a premium multiple. High net retention can compound growth, yet it also makes near-term results sensitive to a smaller set of large accounts and does not establish that bookings or contract value will convert on schedule. Government procurement and budget timing add a separate source of lumpiness. Over 1–3 months, guidance revisions and evidence of U.S. commercial deal conversion matter more than extrapolating another quarter of acceleration. Over 6–18 months, Microsoft, Google, AWS, and data-platform incumbents could pressure pricing or make AI workflows more portable; conversely, demonstrated workflow entrenchment would strengthen Palantir’s pricing power. The bullish article’s 2027–28 revenue path is a scenario, not a defensible base case: a high sales multiple leaves little room for growth to normalize, even if execution remains strong. The reported share weakness may reflect valuation expectations rather than deteriorating fundamentals, but the supplied data cannot establish which. Falsifiers for the growth thesis: consecutive quarters of falling retention, weakening U.S. commercial growth, or guidance cuts; confirmation would be sustained customer expansion alongside conversion of commercial commitments into recognized revenue.

Key Decisions for Investors

• Do not chase the post-results narrative on the assumption that recent acceleration continues indefinitely. Keep exposure sized for meaningful multiple compression as well as execution risk.
• Watch the next 1–3 months for commercial revenue conversion, retention, and guidance changes—not headline contract value alone. Treat a sustained retention decline or a guidance reduction as a thesis review trigger.
• For an existing long, consider a partial hedge with a defined-risk put spread only if option pricing and liquidity make the premium acceptable; those inputs are not provided, so there is no unconditional options recommendation.
• No clean directional trade is supported by this article alone. A pullback is not sufficient by itself to buy: require continued commercial growth and evidence that large customer commitments are converting.